Pro Medicus
PME.AX
#1249
Rank
NZ$24.55 B
Marketcap
$235.05
Share price
3.72%
Change (1 day)
91.17%
Change (1 year)

P/E ratio for Pro Medicus (PME.AX)

P/E ratio at the end of 2023: 111

According to Pro Medicus's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 363.695. At the end of 2023 the company had a P/E ratio of 111.

P/E ratio history for Pro Medicus from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202311119.24%
202292.9-44.33%
202116746.96%
2020113-9.37%
2019125123.62%
201856.015.57%
201748.5-24.9%
201664.513.96%
201556.645.17%
201439.0585.71%
20135.69-45.45%
201210.4-50.27%
201121.0130.97%
20109.08-4.23%
20099.48-2.61%
20089.73-31.32%
200714.2-22.89%
200618.46.26%
200517.323.5%
200414.0-24.72%
200318.69.15%
200217.0-22.86%
200122.1

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.